225430 — KMPharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapSucker Stock

Annual income statement for KMPharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,928	22,705	15,631	17,770	14,475
Cost of Revenue
Gross Profit	5,941	5,663	3,225	4,910	3,606
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	22,216	22,341	17,686	18,869	17,044
Operating Profit	712	364	-2,055	-1,100	-2,569
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	322	-514	-4,574	-964	-4,249
Provision for Income Taxes
Net Income After Taxes	471	-611	-3,925	-1,320	-4,573
Net Income Before Extraordinary Items
Net Income	471	-611	-3,925	-1,320	-4,573
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	471	-611	-3,925	-1,320	-4,573
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	21.8	-10.4	-122	-47.4	-164
Dividends per Share